Omega-3 Blood Test: New Omega Watch Research
A groundbreaking advancement simplifies the way we monitor omega-3 blood levels, offering easier access to crucial details for cardiovascular and cognitive health. This innovative test, developed by researchers at McMaster University and the University of Guelph, focuses on the key omega-3s EPA and DHA. Discover how new biomarkers of the Omega-3 Index are streamlining research and potentially revolutionizing routine screenings. Learn how a deficiency in omega-3 fatty acids can increase health risks, and how this new method helps determine supplementation needs. News directory 3 highlights how this could benefit many. Future research aims to develop a urine-based biomarker.Discover what’s next …
New Test Simplifies Omega-3 Blood Level Tracking
Updated June 27, 2025
A new method developed by researchers at McMaster University and the University of Guelph offers a simpler way to monitor omega-3 fatty acid levels in the bloodstream. This advancement provides easier access to information crucial for maintaining cardiovascular health and cognitive function. The study focuses on improving the tracking of key omega-3s, EPA (eicosatetraenoic acid) and DHA (docosahexaenoic acid).
The body cannot produce sufficient amounts of these essential omega-3 fatty acids; they must be obtained through diet, primarily from fish, seafood, enriched foods, or supplements. A deficiency in omega-3 fatty acids is linked to increased cardiovascular risk, inflammation, cognitive impairment, depression, and issues in fetal neurodevelopment.
The new biomarkers of the Omega-3 Index (O3I) will streamline research into omega-3 fatty acid nutrition, benefiting population health, especially among vulnerable groups. The current method for measuring the Omega-3 Index involves drawing large blood samples and complex lab analysis, making routine measurement uncommon. The new approach paves the way for regular screening, helping clinicians and patients determine necessary supplementation.
Philip Britz-McKibbin, a professor of chemistry and chemical biology at McMaster University and lead author of the study, said, “This reflects that you are what you eat. Omega-3 fatty acids are primarily derived from our diet and are incorporated into the membranes of all cells and tissues in your body. In general, if you have an O3I below 4 percent you may have a higher risk for a cardiovascular-related event. Conversely, individuals with an O3I above 8 percent have a lower risk. But since O3I is a modifiable risk factor,you can change it through diet.”
britz-McKibbin added that individual responses to omega-3 supplementation vary, with different health benefits reported based on whether patients consumed only EPA, only DHA, or a combination.
The study, published in the Journal of Lipid Research, involved participants receiving between 3 and 5 grams of fish oil, EPA, or DHA supplements daily. researchers then used lipid profiling to isolate specific O3I biomarkers from circulating lipids.
“Our test can be part of a routine blood test without any special requirements,” Britz-McKibbin said. “By directly measuring only two specific biomarkers in a blood sample, we can rapidly assess the O3I without time-consuming and costly sample workup protocols prior to analysis.”
What’s next
The research team plans to identify a urine-based biomarker for the O3I, potentially eliminating the need for blood draws altogether, further simplifying omega-3 monitoring.